178 related articles for article (PubMed ID: 7688019)
21. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
Miwa T; Song WC
Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
[TBL] [Abstract][Full Text] [Related]
22. The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria.
Rosse WF
Blood; 1986 Feb; 67(2):268-9. PubMed ID: 2417643
[No Abstract] [Full Text] [Related]
23. Complement regulation.
Meri S; Jarva H
Vox Sang; 1998; 74 Suppl 2():291-302. PubMed ID: 9704459
[TBL] [Abstract][Full Text] [Related]
24. The complement system in human reproduction.
Vanderpuye OA; Labarrere CA; McIntyre JA
Am J Reprod Immunol; 1992; 27(3-4):145-55. PubMed ID: 1384536
[TBL] [Abstract][Full Text] [Related]
25. [Complement regulatory proteins].
Miyagawa S
Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
[No Abstract] [Full Text] [Related]
26. CD59: a molecule involved in antigen presentation as well as downregulation of membrane attack complex.
Venneker GT; Asghar SS
Exp Clin Immunogenet; 1992; 9(1):33-47. PubMed ID: 1379443
[TBL] [Abstract][Full Text] [Related]
27. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
Nilsson B; Hagström U; Englund A; Säfwenberg J
Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
[No Abstract] [Full Text] [Related]
29. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
31. Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.
Wiedmer T; Hall SE; Ortel TL; Kane WH; Rosse WF; Sims PJ
Blood; 1993 Aug; 82(4):1192-6. PubMed ID: 7688991
[TBL] [Abstract][Full Text] [Related]
32. Protection of thyroid cancer cells by complement-regulatory factors.
Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
[TBL] [Abstract][Full Text] [Related]
33. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
34. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
35. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.
Christiansen D; Milland J; Thorley BR; McKenzie IF; Loveland BE
Eur J Immunol; 1996 Mar; 26(3):578-85. PubMed ID: 8605924
[TBL] [Abstract][Full Text] [Related]
36. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
37. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
[No Abstract] [Full Text] [Related]
38. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues.
Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM
APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413
[TBL] [Abstract][Full Text] [Related]
39. Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease.
Mishra N; Mohata M; Narang R; Lakshmy R; Hazarika A; Pandey RM; Das N; Luthra K
Front Immunol; 2019; 10():2072. PubMed ID: 31555286
[TBL] [Abstract][Full Text] [Related]
40. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
Brooimans RA; van Wieringen PA; van Es LA; Daha MR
Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
